Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Functiol (Non Ulcer) Dyspepsia - Overview
Functiol (Non Ulcer) Dyspepsia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Functiol (Non Ulcer) Dyspepsia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Functiol (Non Ulcer) Dyspepsia - Companies Involved in Therapeutics Development
Daewoong Pharmaceutical Co Ltd
ISOThrive Inc
Mitsubishi Tabe Pharma Corp
RaQualia Pharma Inc
Renexxion LLC
Zeria Pharmaceutical Co Ltd
Functiol (Non Ulcer) Dyspepsia - Drug Profiles
5-BIOP - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
acotiamide hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
colestilan chloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ISOT-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mosapride SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ropride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RQ-00000010 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RQ-00201894 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tegoprazan - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Functiol (Non Ulcer) Dyspepsia - Dormant Projects
Functiol (Non Ulcer) Dyspepsia - Discontinued Products
Functiol (Non Ulcer) Dyspepsia - Product Development Milestones
Featured News & Press Releases
Mar 25, 2013: Zeria Pharma Receives Approval For Acofide In Japan For Treating Functiol Dyspepsia
Feb 29, 2012: RaQualia Pharma Receives MHRA Approval To Initiate First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Functional (Non Ulcer) Dyspepsia, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development for Functional (Non Ulcer) Dyspepsia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Functional (Non Ulcer) Dyspepsia - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
Functional (Non Ulcer) Dyspepsia - Pipeline by ISOThrive Inc, 2021
Functional (Non Ulcer) Dyspepsia - Pipeline by Mitsubishi Tanabe Pharma Corp, 2021
Functional (Non Ulcer) Dyspepsia - Pipeline by RaQualia Pharma Inc, 2021
Functional (Non Ulcer) Dyspepsia - Pipeline by Renexxion LLC, 2021
Functional (Non Ulcer) Dyspepsia - Pipeline by Zeria Pharmaceutical Co Ltd, 2021
Functional (Non Ulcer) Dyspepsia - Dormant Projects, 2021
Functional (Non Ulcer) Dyspepsia - Discontinued Products, 2021